nach oben

vorheriger Artikel Prognostic factors and their correlation with s...

nächster Artikel Notes on breast cancer prevention and screening

Tipp

A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years

A patient with somatic type malignancy

Zeitschrift:: memo - Magazine of European Medical Oncology > Ausgabe 3/2015

Autoren:: MD Andreas Edwin Juarso, MD Malte Kiehl, MD Olaf Pfennig, MD Günther Wittenberg, MD Florian Weissinger

» Jetzt Zugang zum Volltext erhalten

Abstract

A 59-year-old patient presented in the outpatient clinic because of an increasing mass in his right buttock. He has a history of a testicular tumor 28 years ago, with increased tumor markers (Human Choriongonadotropin (β-HCG) value 4.9 and Alpha-1 Fetoprotein (AFP) 218 ng/ml).

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Jetzt einloggen Kostenlos registrieren

Collins DH, Pugh RC. Classification and frequency of testicular tumours. Br J Urol. 1964;36:1–11. CrossRefPubMed

Winter E, Kliesch S, Souchon R, de Maike W. Diagnosis of testicular cancer. Dtsch Arztebl. 2005;102:A 3021–5 (Heft 44).

Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79. CrossRefPubMed

Stamatiou K, Papadopoulos P, Perlepes G, Galariotis N, Olympitis M, Moschouris H, Vasilakaki T. Mixed germ tumor of the testicle with ravdomuosarcomatous component: a case report. Cases J. 2009;2:9299. PubMedCentralCrossRefPubMed

Krege S, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol. 2008;53(3):478–96. CrossRefPubMed

Hanna NH, Einhorn LH. Testicular cancer—discoveries and updates. N Engl J Med. 2014;371:2005–16. CrossRefPubMed

Krege S, Albers P, Schmidberger H. Treatment of non-metastatic and moderate metastatic testicular cancer. Dtsch Arztebl. 2005;102:A 3191–4 (Heft 46).

Bokemeyer C, Beyer J, Heidenreich A. Treatment of patients with metastatic germ cell tumors. Dtsch Arztebl. 2005;102:A 3271–5 (Heft 47).

Pottek TS, Hartmann M, Bokemeyer C. Aftercare and delayed toxicity of testicular cancer. Dtsch Arztebl. 2005;102:A 3342–8 (Heft 48).

10.

Gerl A, Clemm C, Schmeller N, Hentrich M, Lamerz R, Wilmanns W. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol. 1997;8(1):41–7. CrossRefPubMed

11.

Oldenburg J, Alfsen GC, Waehre H, Fossá SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer. 2006;94(6):820–7. PubMedCentralCrossRefPubMed

12.

Geldart TR, Gale J, McKendrick J, Kirby J, Mead G. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int. 2006;98(2):353–8. CrossRefPubMed

13.

Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol. 2005;23(28):6999–7004. CrossRefPubMed

14.

15.

Arafat W, Albany C, Ulbright TM, Foster R, Einhorn LH. Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature. J Surg Case Rep. 2014;2014(6):rju051. PubMedCentralCrossRefPubMed

16.

Pavic M, Meeus P, Treilleux I, Droz JP. Malignant teratoma 32 years after treatment of germ cell tumor confined to testis. Urology. 2006;67(4):846. CrossRefPubMed

17.

Plaza JA, Perez-Montiel D, Mayerson J, Morrison C, Suster S. Metastases to soft tissue: a review of 118 cases over a 30-year period. Cancer. 2008;112:193–203. doi: 10.1002/cncr.23151. CrossRefPubMed

18.

Bilici A, Ustaalioglu BB, Seker M, Kayahan S. Soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature. Clin Orthop Relat Res. 2010;468(9):2541–4. PubMedCentralCrossRefPubMed

19.

Oosterhuis JW, Peeters SH, Smit VT, Stoop H, Looijenga LH, Elzevier HW, Osanto S. Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept. Int J Dev Biol. 2013;57(2–4):153–7. CrossRefPubMed

20.

Zeh N, Wild PJ, Bode PK, Kristiansen G, Moch H, Sulser T, Hermanns T. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumor metastasis following platinum-based chemotherapy. BMC Urol. 2013;13:9. PubMedCentralCrossRefPubMed

21.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2013;31(30):3807–14. PubMedCentralCrossRefPubMed

22.

Mesbahi O E, Terrier-Lacombe MJ, Rebischung C, Theodore C, Vanel D, Fizazi K. Chemotherapy in patients with teratoma with malignant transformation. Eur Urol. 2007;51(5):1306–11. CrossRefPubMed

23.

Vaughn DJ, Hwang W, Lal P, Rosen MA, Gallagher M, O’Dwyer PJ. Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors. Cancer. 2015;121(9):1463–8. CrossRefPubMed

Titel: A 59-year-old patient with somatic type malignancy as a relapse of testicular tumor after 28 years
A patient with somatic type malignancy
Autoren:: MD Andreas Edwin Juarso
MD Malte Kiehl
MD Olaf Pfennig
MD Günther Wittenberg
MD Florian Weissinger
Publikationsdatum: 01.09.2015
DOI: https://doi.org/10.1007/s12254-015-0222-8
Verlag: Springer Vienna
Zeitschrift: memo - Magazine of European Medical Oncology An International Journal for Oncology and Haematology Professionals
Ausgabe 3/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076

Springer Medizin Österreich

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

Highlights of the American Society of Hematology Meeting 2014: Hemostaseology

ASH 2014 update: Myelodysplastic syndromes and acute myeloid leukemia

Aggressive lymphoma: news on ASH 2014

Notes on breast cancer prevention and screening

ASH 2014: novel strategies in the management of classical Hodgkin’s lymphoma

Changing treatment paradigms in lymphoma: new targets and new drugs